Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer

Lung cancer is one of the most severe forms of malignancy and a leading cause of cancer-related death worldwide, of which non-small cell lung cancer (NSCLC) is the most primary type observed in the clinic. NSCLC is mainly treated with surgery, radiotherapy, and chemotherapy. Additionally, targeted t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Yang, Ye, Ting, Fu, Siyun, Jiang, Xiaoying, Song, Hang, Liu, Bin, Wang, Guoquan, Wang, Jinghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162406/
https://www.ncbi.nlm.nih.gov/pubmed/37153619
http://dx.doi.org/10.3389/fimmu.2023.1114041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162406/
https://www.ncbi.nlm.nih.gov/pubmed/37153619
http://dx.doi.org/10.3389/fimmu.2023.1114041

Ejemplares similares